Latest filing published 24 Oct 2024 for FIREFLY NEUROSCIENCE, INC.. Read the official filing
No signal scores available.
David Ian Johnson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alliqua BioMedical, Inc. and Firefly Neuroscience, Inc. The record holds 2 filings, for trades running from 9 February 2016 to 22 October 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 24 October 2024, reports a share grant in Firefly Neuroscience, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations